SIN3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.179780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.645400E-01
Normal-vs-Stage2
1.332220E-01
Normal-vs-Stage3
8.594400E-02
Normal-vs-Stage4
5.062000E-01
Stage1-vs-Stage2
5.502400E-01
Stage1-vs-Stage3
2.565900E-02
Stage1-vs-Stage4
9.752400E-01
Stage2-vs-Stage3
1.509810E-01
Stage2-vs-Stage4
6.057000E-01
Stage3-vs-Stage4
9.011800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.161020E-01
Normal-vs-AfricanAmerican
3.605600E-01
Normal-vs-Asian
1.718030E-01
Caucasian-vs-AfricanAmerican
7.273600E-01
Caucasian-vs-Asian
3.524000E-01
AfricanAmerican-vs-Asian
4.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.952400E-02
Normal-vs-Female
1.796380E-01
Male-vs-Female
2.435400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.921600E-01
Normal-vs-Age(41-60Yrs)
2.851200E-01
Normal-vs-Age(61-80Yrs)
7.680400E-02
Normal-vs-Age(81-100Yrs)
1.019950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.397600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.778250E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.442610E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.515300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.962100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.413800E-02
Normal-vs-Daily Drinker
9.598000E-02
Normal-vs-Weekly Drinker
1.432580E-01
Normal-vs-Occasional Drinker
2.697000E-01
Normal-vs-Social Drinker
3.526200E-01
Non Drinker-vs-Daily Drinker
8.540400E-01
Non Drinker-vs-Weekly Drinker
9.380000E-01
Non Drinker-vs-Occasional Drinker
1.305170E-01
Non Drinker-vs-Social Drinker
2.479800E-01
Daily Drinker-vs-Weekly Drinker
8.289200E-01
Daily Drinker-vs-Occasional Drinker
2.014800E-01
Daily Drinker-vs-Social Drinker
3.436000E-01
Weekly Drinker-vs-Occasional Drinker
2.075400E-01
Weekly Drinker-vs-Social Drinker
3.428800E-01
Occasional Drinker-vs-Social Drinker
8.982800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.404800E-01
Normal-vs-Grade 2
2.909900E-02
Normal-vs-Grade 3
2.994200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.288000E-01
Grade 1-vs-Grade 3
3.178000E-01
Grade 1-vs-Grade 4
1.404800E-01
Grade 2-vs-Grade 3
4.249800E-01
Grade 2-vs-Grade 4
2.909900E-02
Grade 3-vs-Grade 4
2.994200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.856500E-02
Normal-vs-NonDiabetic
1.096970E-01
Diabetic-vs-NonDiabetic
3.566600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.039600E-01
Normal-vs-NoPancreatitis
9.871800E-02
Pancreatitis-vs-NoPancreatitis
4.646400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.073400E-01
Normal-vs-N1
1.400790E-01
N0-vs-N1
4.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.386200E-01
Normal-vs-TP53-NonMutant
3.444800E-01
TP53-Mutant-vs-TP53-NonMutant
6.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
